Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 18;220(7):1127–1135. doi: 10.1093/infdis/jiz241

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Antibody responses through 24 months postvaccination by ZEBOV-GP ELISA (A and B) and PRNT (C and D) GMTs (A and C) and seroresponse rates (B and D) in the per-protocol immunogenicity population. N = Number of participants with serology data at 1 or more timepoints according to the treatment to which they were randomized. n = Number of participants contributing to the analysis. Values below the LLOQ (ZEBOV-GP ELISA: <36.11; PRNT: <35) were replaced with ½ LLOQ in GMT calculations. Abbreviations: CI, confidence interval; GMT, geometric mean titer; LLOQ, lower limit of quantification; PRNT, plaque reduction neutralization test; rVSVΔG-ZEBOV-GP, recombinant vesicular stomatitis virus–Zaire Ebola virus envelope glycoprotein vaccine; ZEBOV-GP ELISA, Zaire Ebola virus envelope immunoglobulin G glycoprotein enzyme-linked immunosorbent assay.